Increased transparency is one of the provisions of the Clinical Trial and Medical Device Regulations. This article discusses the impact of transparency and disclosure on medical devices. Many modern-day medical devices are software-driven. These, as well as the patients implanted with or wearing these devices, have become part of the so-called Internet of Things, and are therefore vulnerable to cyber attacks. Disclosure of information, data, and documents pertaining to medical devices will increase this vulner - ability. In the rapidly changing regulatory landscape, the role of medical writers in anonymisation of patient data takes on a whole new magnitude. It is not only about protecting patient privacy, it is about ensuring patient safety
EMA Policy 0070 External guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use. 02 Mar 2016; 16 Dec 2016; 12 Apr 2017
Available from: http://
El Emam K, Jonker E, Arbuckle L, Malin B. A systematic review of re-identification attacks on health data. PLoS One. 2011;6(12):e28071
Available from: http://
El-Laboudi AH, Misra S, Martineau M, Deol P, Sanders A, Oliver N. Intentional large insulin overdose captured on a continuous glucose monitor: a novel case report. J Diabetes Sci Technol. 2015 Jul;9(4):929-31.
Available from: http://
Burns AJ, Johnson ME, Honeyman P. A brief chronology of medical device security. Communications of the ACM 2016 Oct;59(10): 66-72.
Available from: http://